FDA
approval
· 2018-12-14
FDA Approved: HERZUMA — Original Application (Cephalon, Inc.)
Summary
FDA approved Herzuma (trastuzumab) through an original Biologics License Application, establishing it as a biosimilar to trastuzumab for indications in HER2-pos…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for HERZUMA (TRASTUZUMAB)